Skip to search.
 Dow Up 0.11% Nasdaq Up 0.60%

Pfizer, Inc. Common Stock (PFE)

-NYSE

21.48 Up 0.03(0.12%) Mar 9, 4:00PM EST|After Hours: 21.48 0.00 (0.00%) Mar 9, 7:57PM EST

Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Dec 31, 2010Dec 31, 2009
Total Revenue 67,425,000   67,057,000   49,269,000  
Cost of Revenue15,085,000  15,838,000  8,459,000  
Gross Profit 52,340,000   51,219,000   40,810,000  
Operating Expenses
Research Development9,112,000  9,392,000  7,824,000  
Selling General and Administrative21,947,000  23,816,000  15,037,000  
Non Recurring2,934,000  3,326,000  4,398,000  
Others5,585,000  5,403,000  2,877,000  
Total Operating Expenses39,578,000  41,937,000  30,136,000  
Operating Income or Loss 12,762,000   9,282,000   10,674,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -  
Earnings Before Interest And Taxes12,762,000  9,282,000  10,674,000  
Interest Expense -   -   -  
Income Before Tax12,762,000  9,282,000  10,674,000  
Income Tax Expense4,023,000  1,071,000  2,145,000  
Minority Interest(42,000)(31,000)(8,000)
Net Income From Continuing Ops8,739,000  8,211,000  8,529,000  
Non-recurring Events
Discontinued Operations1,312,000  77,000  114,000  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 10,009,000   8,257,000   8,635,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 10,009,000   8,257,000   8,635,000  

Currency in USD.